Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Stopped early · Not applicable
Conditions studied: Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Pain, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Methadone, morphine, or oxycodone may help relieve pain caused by cancer. It is not yet known whether methadone is more effective than morphine or oxycodone in treating pain in patients with cancer. PURPOSE: This randomized clinical trial is studying methadone to see how well it works compared with morphine or oxycodone in treating pain in patients with cancer.
Key facts
- Study ID
- NCT00726830
- Run by
- M.D. Anderson Cancer Center
- People needed
- 1
- Starts
- 2009-03-01
- Expected to finish
- 2010-10-01
- Last updated by the study team
- 2020-09-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Palmetto Hematology Oncology, PC at Gibbs Regional Cancer Center — Spartanburg, South Carolina, United States
- M. D. Anderson Cancer Center at University of Texas — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.